SOURCE: StockCall


June 07, 2012 08:25 ET

Analyst Research on CVS Caremark Corp. and Walgreen Co. - Drug Stores Could Stand to Benefit From Patent Cliff

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Jun 7, 2012) - offers free research on CVS Caremark Corporation (NYSE: CVS) and Walgreen Co. (NYSE: WAG) from the Drug Stores industry. Access these reports by clicking on the links below or by copy and pasting those to your address bar.

Drug stores such as Caremark Corporation and Walgreen Co. could be relatively well positioned for growth this year. The potential of generic drugs is massive, with the number of expected patent expirations for the year exceeding the past five years combined by more than double. This could positively drive up margins for industry players, many of whom also stand to benefit from efficiency initiatives implemented during recession lows taking effect. Register now to have free access to our reports on the Drug Stores industry, and to do so please click the link below. is an online platform where investors doing their due-diligence on the Drug Stores industry can have easy and free access to our analyst research and opinions on CVS Caremark Corporation and Walgreen Co.; investors and shareholders of these companies can simply register for our complimentary reports by clicking on the link below.

Retention remains a key issue for drug stores as competition in the industry is intense. Last quarter, CVS reported an impressive 98 percent retention rate. Meanwhile, Walgreens recently secured an extended multi-year agreement with OptumRx, providing continued access for members of prescription drug benefit plans managed by OptumRx. To see how companies in this industry have grown over the past years and how they are expected to perform in the future, please visit the link below.

However, there remain some potential headwinds in sight. The merger of two out of the three biggest U.S. drug benefit managers, Express Script and Medco, has given rise to a leading force in pharmacy benefits management, which may create a hurdle for certain drug stores' pharmacy services business.

About is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information